Tina Smith Stock Trades

Every transaction in Senator Tina Smith's 2026 disclosure data so far has been a sale. Eight transactions have been reported this year, covering DexCom, Insulet, Berkshire Hathaway, 3M and Marsh & McLennan, and none were purchases. Across the full disclosure record, from January 2018 through May 2026, sales are the largest category: 35 sales against 12 purchases out of 49 total transactions, with the remaining two recorded as exchanges. It is also worth being precise about whose activity this actually reflects. Of those 49 transactions, 38 are attributed to a spouse, 4 are joint, and 7 carry no attribution code at all. None are recorded as Smith's own personal transactions.

The pace of disclosed activity has varied widely by year. 2018 was by far the busiest, with 18 transactions: 3 purchases and 15 sales. Activity then thinned out substantially, with two transactions in 2019, three in 2020, three in 2021 and two in 2022. Purchasing increased to two transactions in 2022 and three in 2023. Those years included purchases of Artivion, Tactile Systems Technology and Northern Lakes Capital IV. The pattern did not revert fully to sales until 2025: 2024 included one purchase and three sales, followed by three sales in 2025 and eight sales in the 2026 data so far.

Recurring Names: Insulet and DexCom

The single most frequently disclosed security is Insulet Corporation (PODD), appearing in eight transactions, all of them sales, stretching from March 2018 to May 2026. Insulet makes Omnipod insulin-delivery systems for people with insulin-dependent diabetes. DexCom (DXCM), the continuous-glucose-monitoring company behind the Dexcom G7 and G6 systems, shows up three times, also exclusively as sales, most recently on May 7, 2026. Notably, DXCM and PODD were sold on the same transaction dates more than once. The disclosure filed May 10, 2026 reports spouse-attributed partial sales of both securities dated April 29 and spouse-attributed full sales of both dated May 7. Each of those four transactions carries a disclosed range of $100,001 to $250,000.

Four 2018 sales appear under ticker CGNT. The security name in each underlying disclosure is Cogentix Medical, Inc., while the database's current ticker mapping identifies CGNT as Cognyte Software Ltd and classifies it under Information Technology. The historical rows are therefore best identified by the security name actually reported in the filings rather than described as transactions in the currently mapped company. Artivion Inc, a maker of aortic and heart-valve medical devices formerly known as CryoLife, is one of the recurring names with purchase-only activity: three purchases between September 2022 and November 2023, two attributed to a spouse and one unspecified. Tactile Systems Technology, a Minneapolis-based maker of compression devices used to treat lymphedema and related conditions, shows a more balanced pattern: two purchases and two sales between June 2018 and November 2024, all spouse-attributed.

Sector Mix and Other Disclosed Names

Where sector data is available, Health Care dominates, accounting for 20 of the 49 disclosed transactions, driven by the device makers named above plus single disclosed sales of Abbott Laboratories and Medtronic. A near-equal 19 transactions carry no sector classification in the underlying data, including rows for Cutera, Cardiovascular Systems, Berkshire Hathaway, Marsh & McLennan and IntriCon. Beyond health care, the current database mapping includes four Information Technology rows, all associated with the CGNT discrepancy described above. It also includes two Consumer Staples sales, General Mills and PepsiCo, both transaction-dated February 11, 2025, and disclosed March 19, two Utilities sales involving NextEra Energy, both partial sales transaction-dated April 4, 2024, one Financials sale involving Huntington Bancshares in November 2025, and one Industrials sale involving 3M in March 2026.

Several disclosures involve securities without public-market tickers in the packet. Surgical Information Sciences, described in the filings as a health-management-systems company, was purchased in four separately reported spouse-attributed transactions, one in each year from 2018 through 2021. Each carries a disclosed range between $1,001 and $50,000. Northern Lakes Capital IV LP, described in its filing as a Minneapolis private-equity vehicle, was the subject of a spouse-attributed purchase dated April 4, 2022, in the $15,001 to $50,000 range. A disclosure filed May 16, 2022, also includes two exchange rows dated June 9, 2021: one identifies TCF Financial Corporation shares as exchanged and Huntington Bancshares shares as received, while the other lists Huntington Bancshares shares as received. The packet classifies both as exchanges rather than purchases or sales.

As of Quantellect's latest published scoring date, August 21, 2026, no Quantellect Score row exists for Smith. Across the broader database, 76 member profiles had a published score, while 73 of the 537 sitting members of Congress had one. For context, 276 of those 537 sitting members have no disclosed transactions at all. Smith's record contains 49 disclosed transactions, distinguishing it from that zero-transaction group without implying a score or ranking that the data does not provide.

Disclosure Notes

Members of Congress must report covered securities transactions involving themselves and their spouses under the Stop Trading on Congressional Knowledge Act (STOCK Act), generally within 30 days of learning of a transaction and no later than 45 days after it occurred. Disclosure filings report transaction amounts in dollar ranges rather than exact amounts, and this profile presents those ranges as filed. Attribution codes reflect who is identified on the underlying disclosure, spouse, joint, or unspecified, and are not evidence of who made the investment decision. Additional detail on reporting requirements is available from the Senate Select Committee on Ethics. This page reflects disclosed transaction data only and is not a statement of present ownership.